| Public issue of 29,78,000 equity shares of face value Rs. 10 each ("Equity Shares") of JFL Life Sciences Limited (the "Company" or the "Issuer") for cash at a price of Rs. 61/- per equity share (including a securities premium of Rs. 51/- per equity share) (the "Issue Price"), aggregating Rs. 18.17 crores ("Issue") of the issue, 1,50,000 equity shares aggregating to
Rs. 0.92 crores will be reserved for subscription by market maker ("Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. issue of 28,28,000 equity shares of face value of Rs. 10/- each at an issue price of Rs. 61/- per equity share aggregating to Rs. 17.25 crores is hereinafter referred to as the "Net Issue". The issue
and the net issue will constitute 27.08% and 25.71%, respectively of the post issue paid up equity share capital of the company.
The face value of the equity share is Rs. 10/- and the issue price is 6.1 times of the face value.
|